Christina Swanson

Title: Christina Swanson: Innovator in Radiation Injury Assessment

Introduction

Christina Swanson is a notable inventor based in Menlo Park, CA. She has made significant contributions to the field of radiation injury assessment through her innovative work. Her expertise and dedication have led to the development of a unique patent that addresses critical health concerns related to ionizing radiation exposure.

Latest Patents

Christina holds a patent for a "Biomarker panel for dose assessment of radiation injury and micro plasma filter." This patent provides materials, systems, and methods for the qualitative assessment of a person's exposure to ionizing radiation. By measuring the amounts of specific biomarkers, the assessment can determine changes compared to corresponding un-irradiated control reference ranges. The biomarkers include alpha-1-Antichymotrypsin (ACT), Fms-related tyrosine kinase 3 ligand (Flt3L), and one or more additional proteins. Christina's innovative approach has the potential to enhance the accuracy of radiation exposure assessments.

Career Highlights

Christina Swanson has built a successful career at SRI International, where she has been able to apply her knowledge and skills in a collaborative environment. Her work has not only advanced scientific understanding but also contributed to practical applications in health and safety.

Collaborations

Throughout her career, Christina has collaborated with esteemed colleagues, including David E. Cooper and Robert Balog. These partnerships have fostered a rich exchange of ideas and have been instrumental in the development of her innovative projects.

Conclusion

Christina Swanson is a pioneering inventor whose work in radiation injury assessment is making a significant impact in the field. Her dedication to innovation and collaboration continues to drive advancements that can improve health outcomes for individuals exposed to ionizing radiation.